Success Metrics

Clinical Success Rate

66.7%

Based on 2 completed trials

Completion Rate

67%(2/3)

Active Trials

1(20%)

Results Posted

100%(2 trials)

Terminated

1(20%)

Phase Distribution

Ph phase_4

20%

Ph not_applicable

20%

Ph phase_2

20%

Ph phase_3

40%

Phase Distribution

Early Stage

Mid Stage

Late Stage

Phase Distribution5 total trials

Phase 2Efficacy & side effects

1(20.0%)

Phase 3Large-scale testing

2(40.0%)

Phase 4Post-market surveillance

1(20.0%)

N/ANon-phased studies

1(20.0%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

66.7%

2 of 3 finished

Non-Completion Rate

33.3%

1 ended early

Currently Active

trials recruiting

Total Trials

all time

Status Distribution

Active(1)

Completed(2)

Terminated(1)

Other(1)

Detailed Status

Completed2

unknown1

Terminated1

Recruiting1

Development Timeline

Analytics

Development Status

Total Trials

Active

Success Rate

66.7%

Most Advanced

Phase 4

Trials by Phase

Phase 21 (20.0%)

Phase 32 (40.0%)

Phase 41 (20.0%)

N/A1 (20.0%)

Trials by Status

unknown120%

terminated120%

recruiting120%

completed240%

Recent Activity

1 active trials

Showing 5 of 5

recruitingphase_4

Choline Fenofibrate and Carotid Atherosclerosis in Patients With Type 2 Diabetes and Combined Dyslipidemia

NCT05365425

completednot_applicable

Clinical Trials (5)

Showing 5 of 5 trials

NCT05365425Phase 4

Choline Fenofibrate and Carotid Atherosclerosis in Patients With Type 2 Diabetes and Combined Dyslipidemia

Recruiting

NCT00510809Not Applicable

Effect of Policosanol as Monotherapy and Adjunctive to Statin Therapy

Completed

NCT02543099Phase 3

Efficacy and Safety Study of Policosanol

Unknown

NCT00312923Phase 2

Preliminary Study of Safety and Efficacy of Policosanol

Completed

NCT00288483Phase 3

Cholesterol-Lowering Effects of Policosanol

Terminated

All 5 trials loaded

Drug Details

Intervention Type: DRUG
Total Trials: 5